{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:06:53Z","timestamp":1790701613842,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.retram.2026.103592","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:56:28Z","timestamp":1779231388000},"page":"103592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A fault tree analysis of early treatment failure in Acute myeloid leukemia"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5859-5849","authenticated-orcid":false,"given":"Mobina","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salina","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.retram.2026.103592_bib0001","first-page":"1345","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood, J Am Soc Hematol"},{"key":"10.1016\/j.retram.2026.103592_bib0002","doi-asserted-by":"crossref","DOI":"10.1002\/aac2.70018","article-title":"Prognostic impact of european leukemianet genetic risk stratification system in adult patients with acute myeloid leukemia","author":"Shrestha","year":"2026","journal-title":"Aging Cancer"},{"key":"10.1016\/j.retram.2026.103592_bib0003","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1182\/blood-2025-7031","article-title":"Age-specific impact of apoptosis gene expression and recurrent mutations on remission and survival in AML: a machine learning-based analysis","volume":"146","author":"Shrestha","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.retram.2026.103592_bib0004","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1182\/blood-2025-7024","article-title":"Identifying AML patients most likely to benefit from venetoclax using apoptotic gene ratios","volume":"146","author":"Shrestha","year":"2025","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2026.103592_bib0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41408-024-01186-5","article-title":"What have we learned about TP53-mutated acute myeloid leukemia?","volume":"14","author":"Shahzad","year":"2024","journal-title":"Blood Cancer J"},{"issue":"11","key":"10.1016\/j.retram.2026.103592_bib0006","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/leu.2016.126","article-title":"RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features","volume":"30","author":"Gaidzik","year":"2016","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.retram.2026.103592_bib0007","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.retram.2026.103592_bib0008","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","article-title":"TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes","volume":"375","author":"Welch","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.retram.2026.103592_bib0009","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/imj.70086","article-title":"Frailty and geriatric assessments in older patients diagnosed with acute myeloid leukaemia: an Australasian Leukaemia and Lymphoma Group consensus statement","volume":"55","author":"Shaw","year":"2025","journal-title":"Intern Med J"},{"issue":"5","key":"10.1016\/j.retram.2026.103592_bib0010","first-page":"515","article-title":"Frailty and the management of hematologic malignancies. Blood","volume":"131","author":"Abel","year":"2018","journal-title":"J Am Soc Hematol"},{"issue":"6","key":"10.1016\/j.retram.2026.103592_bib0011","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00277-020-04375-x","article-title":"Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML","volume":"100","author":"Laribi","year":"2021","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.retram.2026.103592_bib0012","first-page":"4061","article-title":"Early mortality in acute promyelocytic leukemia: Potential predictors","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.retram.2026.103592_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.562558","article-title":"Venetoclax-based combinations in acute myeloid leukemia: current evidence and future directions","volume":"10","author":"Samra","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.retram.2026.103592_bib0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barab\u00e1si","year":"2011","journal-title":"Nat Rev Genet"},{"issue":"5560","key":"10.1016\/j.retram.2026.103592_bib0015","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1069492","article-title":"Systems biology: a brief overview","volume":"295","author":"Kitano","year":"2002","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.retram.2026.103592_bib0016","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbcan.2009.06.001","article-title":"A systems biology view of cancer","volume":"1796","author":"Laubenbacher","year":"2009","journal-title":"Biochim Biophys Acta (BBA)-Rev Cancer"},{"issue":"19","key":"10.1016\/j.retram.2026.103592_bib0017","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-12-2217","article-title":"Intratumor heterogeneity: evolution through space and time","volume":"72","author":"Swanton","year":"2012","journal-title":"Cancer Res"},{"issue":"7381","key":"10.1016\/j.retram.2026.103592_bib0018","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.retram.2026.103592_bib0019","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.retram.2026.103592_bib0020","author":"Vesely","year":"1981","journal-title":"Fault Tree Handb"},{"issue":"8","key":"10.1016\/j.retram.2026.103592_bib0021","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.retram.2026.103592_bib0022","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.retram.2026.103592_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100554","article-title":"Dysnatremias, mortality, and kidney failure in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"4","author":"Hassanein","year":"2022","journal-title":"Kidney Med"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:30:25Z","timestamp":1790699425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318626000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2452318626000280"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2026.103592","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fault tree analysis of early treatment failure in Acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2026.103592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103592"}}